Skip to main content
. Author manuscript; available in PMC: 2021 May 1.
Published in final edited form as: Circ Arrhythm Electrophysiol. 2020 Apr 12;13(5):e007669. doi: 10.1161/CIRCEP.119.007669

Table 5.

Baseline, procedural, and clinical differences between patients deceased versus alive at the time of discharge

Died during index hospitalization (n=6) Alive at discharge (n=15)
Male gender 4 (67%) 14 (93%)
Age 69 [52–72.5] 67 [49.5–68]
LVEF 19 [15.75–20] 30 [17–35]
PAINESD score 20.5 [15–23] 17 [14–20]
Clinical VT non-inducible* 2/4 (50%) 6 (60%)
ICM 5 (83%) 13 (87%)
NICM 1 (17%) 3 (20%)
Prior VT ablation 2 (33%) 5 (33%)
Number of home AADs 1 [0.25–1] 0 [0–1]
Duration in cardiogenic shock prior to procedure (days) 9 [5.25–12.75] 4 [1.5–6.5]
Duration in cardiogenic shock after to procedure (days) 9 [3.5–10.75] 3 [1–4.5]
Total duration in cardiogenic shock (days) 13 [11.25–21.5] 8 [4.5–9.5]
*

In patients with baseline inducible ventricular tachycardia